Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab therapy in rheumatoid arthritis.
Keystone E, Haraoui B. Keystone E, et al. Rheum Dis Clin North Am. 2004 May;30(2):349-64, vii. doi: 10.1016/j.rdc.2004.02.004. Rheum Dis Clin North Am. 2004. PMID: 15172045 Review.
Therapeutic targets for rheumatoid arthritis.
Keystone EC, Haraoui B. Keystone EC, et al. J Rheumatol Suppl. 2009 Jun;82:1. doi: 10.3899/jrheum.090123. J Rheumatol Suppl. 2009. PMID: 19509323 No abstract available.
Response times follow lognormal or gamma distribution in arthritis patients.
Abrahamyan L, Beyene J, Feng J, Chon Y, Willan AR, Schmeling H, Horneff G, Keystone EC, Feldman BM. Abrahamyan L, et al. Among authors: keystone ec. J Clin Epidemiol. 2010 Dec;63(12):1363-9. doi: 10.1016/j.jclinepi.2009.11.019. J Clin Epidemiol. 2010. PMID: 20430577 Clinical Trial.
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.
Hitchon CA, Boire G, Haraoui B, Keystone E, Pope J, Jamal S, Tin D, Thorne C, Bykerk VP; CATCH investigators. Hitchon CA, et al. Rheumatology (Oxford). 2016 Oct;55(10):1751-62. doi: 10.1093/rheumatology/kew061. Epub 2016 Jun 21. Rheumatology (Oxford). 2016. PMID: 27330161
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
Kivitz AJ, Cohen S, Keystone E, van Vollenhoven RF, Haraoui B, Kaine J, Fan H, Connell CA, Bananis E, Takiya L, Fleischmann R. Kivitz AJ, et al. Semin Arthritis Rheum. 2018 Dec;48(3):406-415. doi: 10.1016/j.semarthrit.2018.07.006. Epub 2018 Jul 19. Semin Arthritis Rheum. 2018. PMID: 30177460 Free article. Clinical Trial.
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry.
Rahman P, Baer P, Keystone E, Choquette D, Thorne C, Haraoui B, Chow A, Faraawi R, Olszynski W, Kelsall J, Rampakakis E, Lehman AJ, Nantel F. Rahman P, et al. BMC Rheumatol. 2020 Sep 19;4:46. doi: 10.1186/s41927-020-00145-4. eCollection 2020. BMC Rheumatol. 2020. PMID: 32968710 Free PMC article.
296 results